Cargando…
Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820129/ https://www.ncbi.nlm.nih.gov/pubmed/35144877 http://dx.doi.org/10.1016/j.hlc.2022.01.001 |
_version_ | 1784646178812461056 |
---|---|
author | Gräni, Christoph |
author_facet | Gräni, Christoph |
author_sort | Gräni, Christoph |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8820129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88201292022-02-08 Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare Gräni, Christoph Heart Lung Circ Letter to the Editor Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. 2022-05 2022-02-07 /pmc/articles/PMC8820129/ /pubmed/35144877 http://dx.doi.org/10.1016/j.hlc.2022.01.001 Text en © 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Gräni, Christoph Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title | Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title_full | Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title_fullStr | Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title_full_unstemmed | Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title_short | Reply: Takotsubo Cardiomyopathy After Receiving mRNA COVID-19 Vaccination is Very Rare |
title_sort | reply: takotsubo cardiomyopathy after receiving mrna covid-19 vaccination is very rare |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820129/ https://www.ncbi.nlm.nih.gov/pubmed/35144877 http://dx.doi.org/10.1016/j.hlc.2022.01.001 |
work_keys_str_mv | AT granichristoph replytakotsubocardiomyopathyafterreceivingmrnacovid19vaccinationisveryrare |